Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IONIC trial: IMU-838 plus oseltamivir in adults with COVID-19
2020-001805-21Phase 2Unknown
- Sponsor
- University Hospitals Coventry and Warwickshire NHS Trust
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vidofludimus calcium in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by University Hospitals Coventry and Warwickshire NHS Trust. Primary endpoint: Time to clinical improvement. Status: unknown.
02
Drugs
vidofludimus calcium
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2020-001805-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001805-21.